Dr. Kevin J. Callerame, MD

Dr. Callerame practices at Our Lady of the Lake Physician Group in Baton Rouge, Louisiana.

Dr. Callerame's NPI, 1245229459, was assigned on October 19, 2005. Dr. Callerame graduated from Tulane School of Medicine in 1990. Dr. Callerame holds Louisiana license 020960.

Dr. Callerame's primary practice is Our Lady of the Lake Physician Group, at 5247 Didesse Dr, Baton Rouge, LA 70808 in East Baton Rouge Parish. The practice phone is (225) 765-7727.

Dr. Callerame's primary practice is Our Lady of the Lake Physician Group in Baton Rouge, Louisiana. Dr. Callerame is also affiliated with Our Lady of the Lake Regional Medical Center. The medical group on file is Our Lady of the Lake Physician Group. Dmand AI also links Dr. Callerame to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Callerame practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Callerame's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Callerame is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Callerame's licenses on file in 3 states: Louisiana, Arizona and Florida.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, encephalopathy, epilepsy, fibromyalgia and chronic pain and head injury among the conditions Dr. Callerame treats.

CMS data shows 9,880 Medicare services from Dr. Callerame across 8 procedure codes in 2024, for 345 Medicare patients. Medicare paid $95,506 for them.

CMS counts 345 Medicare patients who saw Dr. Callerame in 2024. The largest group is 65 to 74, with 132 patients. 73% of them have high cholesterol, and 72% have high blood pressure. 29% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Callerame's median patient age at 60, with 61% women.

In 2024, Dr. Callerame wrote 7,673 Medicare Part D claims for 813 patients. 80% of them were for generic drugs. CMS names the drug for 7,367 of them, across 108 drugs with 11 or more claims each, at $7,109,440 in total drug cost. In 2023, CMS named 7,387 claims across 105 drugs.

Dr. Callerame accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Callerame as offering telehealth.

Dmand AI links 2 papers to Dr. Callerame in 2015. Dr. Callerame's most frequent co-authors are Anthony Liberato Petraglia, MD and Corey Tyler Walker, MD.

CMS Open Payments shows 3,665 general payments to Dr. Callerame from 98 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 79% of the total. Abbvie Inc. paid the most, $270,745.

Dr. Callerame graduated from Tulane School of Medicine in 1990.

Dr. Callerame is in network with 18 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.